Baker McKenzie advised CSL in its strategic partnership with Thermo Fisher
CSL enters partnership with Thermo Fisher Scientific, a global biotechnology company with a dynamic portfolio of life-saving medicines. The strategic partnership was created to help meet the increasing demand for biologic therapies while also accelerating CSL’s broader manufacturing objectives. Through a long-term lease agreement with CSL, Thermo Fisher will operate a new state-of-the-art biologics manufacturing facility in Lengnau, Switzerland, when construction is completed in 2021.
